• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
"Cleavable trifunctional" approach to receptor affinity labeling: chemical regeneration of binding to A1-adenosine receptors.受体亲和标记的“可裂解三功能”方法:与A1-腺苷受体结合的化学再生
Bioconjug Chem. 1995 May-Jun;6(3):255-63. doi: 10.1021/bc00033a004.
2
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.纹状体A2a腺苷受体的化学修饰与不可逆抑制
Mol Pharmacol. 1992 Jul;42(1):123-33.
3
High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.A1腺苷受体的高亲和力酰化拮抗剂:结合亚基的鉴定
Mol Pharmacol. 1988 Dec;34(6):724-8.
4
Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.作为定制配体性质设计策略的三功能试剂:A1腺苷受体的不可逆抑制剂
Bioconjug Chem. 1991 Mar-Apr;2(2):77-88. doi: 10.1021/bc00008a002.
5
A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.豚鼠大脑皮层中A1腺苷受体对环磷酸腺苷形成及放射性配体结合的抑制作用。
Br J Pharmacol. 1994 Dec;113(4):1501-7. doi: 10.1111/j.1476-5381.1994.tb17166.x.
6
TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A ADENOSINE RECEPTOR.三功能配体:一种用于A1腺苷受体的放射性碘化高亲和力酰化拮抗剂。
Pharmacol Commun. 1992;1(2):145-154.
7
Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.放射性配体[3H]-SCH 58261(一种新型非黄嘌呤类A2A腺苷受体拮抗剂)与大鼠纹状体膜的结合。
Br J Pharmacol. 1996 Apr;117(7):1381-6. doi: 10.1111/j.1476-5381.1996.tb15296.x.
8
Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.利用放射性配体结合和光亲和标记对人纹状体A2-腺苷受体进行表征。
J Recept Res. 1992;12(2):149-69. doi: 10.3109/10799899209074789.
9
Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.DDT1 MF-2平滑肌细胞中A1和A2腺苷受体的证实。
Mol Pharmacol. 1990 Feb;37(2):149-56.
10
Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.锌离子和镉离子对大鼠脑内激动剂与腺苷A1受体结合的抑制作用机制
Biochem Pharmacol. 1999 Aug 15;58(4):623-32. doi: 10.1016/s0006-2952(99)00135-5.

引用本文的文献

1
Corroboration of Zn(ii)-Mg(ii)-tertiary structure interplays essential for the optimal catalysis of a phosphorothiolate thiolesterase ribozyme.锌(II)-镁(II)-三级结构相互作用的证实对于硫代磷酸酯硫酯酶核酶的最佳催化至关重要。
RSC Adv. 2018 Sep 21;8(57):32775-32793. doi: 10.1039/c8ra05083j. eCollection 2018 Sep 18.
2
Synthesis and characterization of degradable multivalent cationic lipids with disulfide-bond spacers for gene delivery.用于基因递送的具有二硫键间隔基的可降解多价阳离子脂质的合成与表征
Biochim Biophys Acta. 2011 Sep;1808(9):2156-66. doi: 10.1016/j.bbamem.2011.04.020. Epub 2011 May 24.
3
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.国际基础和临床药理学联合会. LXXXI. 腺苷受体的命名和分类-更新。
Pharmacol Rev. 2011 Mar;63(1):1-34. doi: 10.1124/pr.110.003285. Epub 2011 Feb 8.
4
Recent developments in adenosine receptor ligands and their potential as novel drugs.腺苷受体配体的最新进展及其作为新型药物的潜力。
Biochim Biophys Acta. 2011 May;1808(5):1290-308. doi: 10.1016/j.bbamem.2010.12.017. Epub 2010 Dec 23.
5
Xanthines as adenosine receptor antagonists.作为腺苷受体拮抗剂的黄嘌呤类药物。
Handb Exp Pharmacol. 2011(200):151-99. doi: 10.1007/978-3-642-13443-2_6.
6
Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).功能化同系物方法设计 G 蛋白偶联受体 (GPCR) 的配体。
Bioconjug Chem. 2009 Oct 21;20(10):1816-35. doi: 10.1021/bc9000596. Epub 2009 Apr 30.
7
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies.氟磺酰基和双(β-氯乙基)氨基-苯基氨基官能化的吡唑并[4,3-e]1,2,4-三唑并[1,5-c]嘧啶衍生物:人A3腺苷受体的不可逆拮抗剂及分子模拟研究
J Med Chem. 2001 Aug 16;44(17):2735-42. doi: 10.1021/jm010818a.
8
Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptors.1,4 - 二氢吡啶的功能化同系物作为A3腺苷受体的拮抗剂分子探针
Bioconjug Chem. 1999 Jul-Aug;10(4):667-77. doi: 10.1021/bc9900136.
9
Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.毒蕈碱受体的分子探针:选择性毒蕈碱拮抗剂的功能化类似物。
Life Sci. 1995;56(11-12):823-30. doi: 10.1016/0024-3205(95)00016-y.

本文引用的文献

1
TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A ADENOSINE RECEPTOR.三功能配体:一种用于A1腺苷受体的放射性碘化高亲和力酰化拮抗剂。
Pharmacol Commun. 1992;1(2):145-154.
2
Molecular Characterization of A(1) and A(2a) Adenosine Receptors.A(1)和A(2a)腺苷受体的分子特征
Drug Dev Res. 1993 Mar;28(3):226-231. doi: 10.1002/ddr.430280307. Epub 2004 Oct 5.
3
A new heterobifunctional cross-linking reagent for the study of biological interactions between proteins. I. Design, synthesis, and characterization.一种用于研究蛋白质间生物相互作用的新型异双功能交联剂。I. 设计、合成与表征。
J Biol Chem. 1981 May 25;256(10):5064-70.
4
125I-labeled crosslinking reagent that is hydrophilic, photoactivatable, and cleavable through an azo linkage.125I标记的交联剂,具有亲水性、可光活化且可通过偶氮键裂解。
Proc Natl Acad Sci U S A. 1984 Sep;81(17):5286-90. doi: 10.1073/pnas.81.17.5286.
5
The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.通过与含¹²⁵I的酰化剂结合将蛋白质标记至高比放射性。
Biochem J. 1973 Jul;133(3):529-39. doi: 10.1042/bj1330529.
6
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.抑制常数(K1)与导致酶促反应50%抑制率(I50)的抑制剂浓度之间的关系。
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108. doi: 10.1016/0006-2952(73)90196-2.
7
A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.一种新型高亲和力碘化腺苷受体拮抗剂,用作放射性配体/光亲和交联探针。
Mol Pharmacol. 1987 Aug;32(1):184-8.
8
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.A1选择性腺苷拮抗剂8-环戊基-1,3-二丙基黄嘌呤与大鼠脑膜的结合。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59-63. doi: 10.1007/BF00165037.
9
8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.8-取代黄嘌呤作为A1和A2腺苷受体拮抗剂。
Biochem Pharmacol. 1988 Oct 1;37(19):3653-61. doi: 10.1016/0006-2952(88)90398-x.
10
Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.1,3 - 二烷基黄嘌呤的功能化类似物:对腺苷受体具有高亲和力的类似物的制备
J Med Chem. 1985 Sep;28(9):1334-40. doi: 10.1021/jm00147a038.

受体亲和标记的“可裂解三功能”方法:与A1-腺苷受体结合的化学再生

"Cleavable trifunctional" approach to receptor affinity labeling: chemical regeneration of binding to A1-adenosine receptors.

作者信息

Jacobson K A, Fischer B, Ji X D

机构信息

Molecular Recognition Section, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Bioconjug Chem. 1995 May-Jun;6(3):255-63. doi: 10.1021/bc00033a004.

DOI:10.1021/bc00033a004
PMID:7632796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3476064/
Abstract

A general approach for reversible affinity labeling of receptors has been developed. The objective is to carry out a series of chemical modifications resulting in a covalently-modified, yet functionally-regenerated, receptor protein that also may contain a reporter group. The ligand recognition site of A1-adenosine receptors in bovine brain membranes was probed to demonstrated the feasibility of this approach. Use of disulfide or ester linkages, intended for cleavage by exposure of the labeled receptor to either reducing reagents or hydroxylamine, respectively, was considered. Binding of the antagonist radioligand [3H]CPX was preserved following incubation of the native receptor with 3 M hydroxylamine, while binding was inhibited by the reducing reagent dithiothreitol (DTT) with an IC50 of 0.29 M. Hydroxylamine displaced specific agonist ([3H]PIA) binding in a noncovalent manner. Specific affinity labels containing reactive isothiocyanate groups were synthesized from XCC (8-4--oxy]phenyl]-1,3-dipropylxanthine) and shown to bind irreversibly to A1-receptors. The ligands were structurally similar to previously reported xanthine inhibitors (e.g., DITC-XAC: (1989) J. Med. Chem. 32, 1043) except that either a disulfide linkage or an ester linkage was incorporated in the chain between the pharmacophore and the isothiocyanate-substituted ring. These groups were intended for chemical cleavage by thiols or hydroxylamine, respectively. Radioligand binding to A1-receptors was inhibited by these reactive xanthines in a manner that was not reversed by repeated washing. Hydroxylamine or DTT restored a significant fraction of the binding of [3H]CPX in A1-receptors inhibited by the appropriate cleavable xanthine isothiocyanate derivative.

摘要

已开发出一种用于受体可逆亲和标记的通用方法。目的是进行一系列化学修饰,从而得到一种经共价修饰但功能可恢复的受体蛋白,该蛋白还可能含有一个报告基团。对牛脑膜中A1 - 腺苷受体的配体识别位点进行了探测,以证明该方法的可行性。考虑使用二硫键或酯键,分别通过将标记的受体暴露于还原剂或羟胺来进行裂解。天然受体与3 M羟胺孵育后,拮抗剂放射性配体[3H]CPX的结合得以保留,而还原剂二硫苏糖醇(DTT)以0.29 M的IC50抑制结合。羟胺以非共价方式取代特异性激动剂([3H]PIA)的结合。由XCC(8 - 4 - -氧基]苯基]-1,3 - 二丙基黄嘌呤)合成了含有反应性异硫氰酸酯基团的特异性亲和标记物,并显示其与A1受体不可逆结合。这些配体在结构上与先前报道的黄嘌呤抑制剂(例如,DITC - XAC: (1989) J. Med. Chem. 32, 1043)相似,只是在药效基团和异硫氰酸酯取代环之间的链中引入了二硫键或酯键。这些基团分别旨在通过硫醇或羟胺进行化学裂解。这些反应性黄嘌呤以一种经反复洗涤不能逆转的方式抑制放射性配体与A1受体的结合。羟胺或DTT可恢复在被适当的可裂解黄嘌呤异硫氰酸酯衍生物抑制的A1受体中[3H]CPX结合的很大一部分。